Health care professional M.J. Hager said in an interview that aired Monday on Hill.TV’s “Rising” that the technology company Hippo has revamped the prescription drug industry by giving patients access to low drug prices.
“It’s really just a basic technology that has transformed and disrupted this industry,” Hager, Hippo’s chief patient advocate, told hosts Krystal Ball and Buck Sexton earlier this year.
“This industry is just clouded in price obscurity, and in every other industry we have all of this transparency that leads to lower prices and competition and consumers being informed,” she continued.
“Hippo has built a technology but more importantly great relationships with every step of the process, with every major pharmaceutical chain and benefits managers and insurance companies and drug companies,” she continued.
“Through their superior technology and relationships, they’re able to offer just rock-bottom prices,” she said.
The Hippo phone application is accepted at over 70,000 pharmacies in the U.S., and allows users to compare drug prices.
A Kaiser Family Foundation poll released earlier this month found that 79 percent of respondents called drug prices in the U.S. “unreasonable.”
The Trump administration and Congress are in the process of working to lower prescription drug prices.
The Senate Finance Committee announced last week that it scored commitments from executives of five major pharmacy benefit managers to testify next month about the high costs of prescription drugs.
— Julia Manchester
hilltv copyright